EMILY WAGNER: Open Payments
NPI 1982019865 · BROOKLYN, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$545 in 27 payments from 14 companies in 2025. Trend: 2023 $681 · 2024 $692 · 2025 $545
Food & beverage: $545
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $88 |
| Teva Pharmaceuticals USA, Inc. | 3 | $73 |
| Novo Nordisk Inc | 3 | $55 |
| Exact Sciences Corporation | 3 | $53 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $50 |
| Amgen Inc. | 3 | $45 |
| HARMONY BIOSCIENCES LLC | 2 | $32 |
| Phathom Pharmaceuticals, Inc. | 1 | $29 |
| Dexcom, Inc. | 1 | $26 |
| Lundbeck LLC | 1 | $21 |
Products named: VRAYLAR, AUSTEDO XR, The Cologuard Plus Collection Kit, XIFAXAN, EVENITY, WAKIX, VOQUEZNA, Dexcom G6 Transmitter.
Industry payments across IA — which companies pay providers there.
